Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 730

1.

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.

Sethi S, Donohue JF, Ferguson GT, Barnes CN, Crater GD.

Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620905278. doi: 10.1177/1753466620905278.

2.

Anthropometric, physiological characteristics and rugby-specific game skills of schoolboy players of different age categories and playing standards.

Chiwaridzo M, Ferguson GD, Smits-Engelsman BCM.

BMC Sports Sci Med Rehabil. 2020 Feb 10;12:3. doi: 10.1186/s13102-019-0155-3. eCollection 2020.

3.

Intimate partner violence in Nepal: Latent patterns and association with depressive symptoms.

Clark CJ, Cheong YF, Gupta J, Ferguson G, Shrestha B, Shrestha PN, Yount KM.

SSM Popul Health. 2019 Nov 20;9:100481. doi: 10.1016/j.ssmph.2019.100481. eCollection 2019 Dec.

4.

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD.

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 23;14:2993-3002. doi: 10.2147/COPD.S220861. eCollection 2019.

5.

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 23;14:2979-2991. doi: 10.2147/COPD.S220850. eCollection 2019.

6.

Impact of the Change Starts at Home Trial on Women's experience of intimate partner violence in Nepal.

Clark CJ, Shrestha B, Ferguson G, Shrestha PN, Calvert C, Gupta J, Batayeh B, Bergenfeld I, Oakes JM.

SSM Popul Health. 2019 Dec 13;10:100530. doi: 10.1016/j.ssmph.2019.100530. eCollection 2020 Apr.

7.

Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.

Bourdin A, Shaw D, Menzies-Gow A, FitzGerald JM, Bleecker ER, Busse WW, Ferguson GT, Brooks L, Barker P, Gil EG, Martin UJ.

J Asthma. 2019 Dec 26:1-9. doi: 10.1080/02770903.2019.1705333. [Epub ahead of print]

PMID:
31859541
8.

Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma.

FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ.

J Asthma Allergy. 2019 Dec 9;12:401-413. doi: 10.2147/JAA.S227170. eCollection 2019.

9.

Gender dysphoria: puberty blockers and loss of bone mineral density.

Ferguson G, Simm P, O'Connell M, Pang KC.

BMJ. 2019 Dec 4;367:l6471. doi: 10.1136/bmj.l6471. No abstract available.

PMID:
31801730
10.

Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson's disease.

Leonard H, Blauwendraat C, Krohn L, Faghri F, Iwaki H, Ferguson G, Day-Williams AG, Stone DJ, Singleton AB, Nalls MA, Gan-Or Z; International Parkinson's Disease Genomic Consortium (IPDGC).

J Med Genet. 2019 Nov 29. pii: jmedgenet-2019-106283. doi: 10.1136/jmedgenet-2019-106283. [Epub ahead of print]

PMID:
31784483
11.

Being there: A scoping review of grief support training in medical education.

Sikstrom L, Saikaly R, Ferguson G, Mosher PJ, Bonato S, Soklaridis S.

PLoS One. 2019 Nov 27;14(11):e0224325. doi: 10.1371/journal.pone.0224325. eCollection 2019.

12.

Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results.

Ferguson GT, Cole J, Aurivillius M, Roussel P, Barker P, Martin UJ; GRECO study investigators.

J Asthma Allergy. 2019 Oct 23;12:363-373. doi: 10.2147/JAA.S224266. eCollection 2019.

13.

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.

Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Reisner C, Dorinsky P.

Respir Med. 2019 Oct - Nov;158:59-66. doi: 10.1016/j.rmed.2019.08.010. Epub 2019 Aug 22.

PMID:
31605923
14.

Spatial control of heavy-fermion superconductivity in CeIrIn5.

Bachmann MD, Ferguson GM, Theuss F, Meng T, Putzke C, Helm T, Shirer KR, Li YS, Modic KA, Nicklas M, König M, Low D, Ghosh S, Mackenzie AP, Arnold F, Hassinger E, McDonald RD, Winter LE, Bauer ED, Ronning F, Ramshaw BJ, Nowack KC, Moll PJW.

Science. 2019 Oct 11;366(6462):221-226. doi: 10.1126/science.aao6640.

PMID:
31601766
15.

Judging heel height: A new test for proprioception while standing reveals that young hypermobile children perform better than controls.

Ituen OA, Smits-Engelsman B, Ferguson G, Duysens J.

Gait Posture. 2020 Jan;75:8-13. doi: 10.1016/j.gaitpost.2019.09.012. Epub 2019 Sep 23.

PMID:
31586753
16.

Benefits of Activity-Based Interventions Among Female Adolescents Who Are Overweight and Obese.

Bonney E, Ferguson G, Burgess T, Smits-Engelsman B.

Pediatr Phys Ther. 2019 Oct;31(4):338-345. doi: 10.1097/PEP.0000000000000636.

PMID:
31568378
17.

Anthropometric, physiological characteristics and rugby-specific game skills discriminating Zimbabwean under-16 male adolescent rugby players by level of competition.

Chiwaridzo M, Ferguson GD, Smits-Engelsman BCM.

BMJ Open Sport Exerc Med. 2019 Aug 21;5(1):e000576. doi: 10.1136/bmjsem-2019-000576. eCollection 2019.

18.

How do cancer-sniffing dogs sort biological samples? Exploring case-control samples with non-targeted LC-Orbitrap, GC-MS, and immunochemistry methods.

Pleil JD, Wallace MAG, McCord J, Madden MC, Sobus J, Ferguson G.

J Breath Res. 2019 Nov 19;14(1):016006. doi: 10.1088/1752-7163/ab433a.

PMID:
31505485
19.
20.

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.

Kerwin EM, Ferguson GT, Mo M, DeAngelis K, Dorinsky P.

Respir Res. 2019 Jul 29;20(1):167. doi: 10.1186/s12931-019-1126-7.

21.

Family physicians and health advocacy: Is it really a difficult fit?

Bernard C, Soklaridis S, Paton M, Fung K, Fefergrad M, Andermann L, Johnson A, Ferguson G, Iglar K, Whitehead CR.

Can Fam Physician. 2019 Jul;65(7):491-496.

22.

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD.

Maltais F, Ferguson GT, Feldman GJ, Deslee G, Bourdin A, Fjällbrant H, Siwek-Posłuszna A, Jenkins MA, Martin UJ.

Adv Ther. 2019 Sep;36(9):2434-2449. doi: 10.1007/s12325-019-01015-3. Epub 2019 Jul 2.

PMID:
31267366
23.

Conventional Oil-The Forgotten Part of the Water-Energy Nexus.

McIntosh JC, Ferguson G.

Ground Water. 2019 Sep;57(5):669-677. doi: 10.1111/gwat.12917. Epub 2019 Jun 30.

PMID:
31183853
24.

Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.

Ferguson GT, Feldman G, Pudi KK, Barnes CN, Moran EJ, Haumann B, Pendyala S, Crater G.

Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):154-165. doi: 10.15326/jcopdf.6.2.2018.0152. Epub 2019 Apr 9.

25.

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.

Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E.

Int J Chron Obstruct Pulmon Dis. 2019 Mar 22;14:667-682. doi: 10.2147/COPD.S189138. eCollection 2019.

26.

Neutrophil GM-CSF receptor dynamics in acute lung injury.

De Alessandris S, Ferguson GJ, Dodd AJ, Juss JK, Devaprasad A, Piper S, Wyatt O, Killick H, Corkill DJ, Cohen ES, Pandit A, Radstake TRDJ, Simmonds R, Condliffe AM, Sleeman MA, Cowburn AS, Finch DK, Chilvers ER.

J Leukoc Biol. 2019 Jun;105(6):1183-1194. doi: 10.1002/JLB.3MA0918-347R. Epub 2019 Apr 3.

27.

"Change Really Does Need to Start From Home": Impact of an Intimate Partner Violence Prevention Strategy Among Married Couples in Nepal.

McGhee S, Shrestha B, Ferguson G, Shrestha PN, Bergenfeld I, Clark CJ.

J Interpers Violence. 2019 Mar 28:886260519839422. doi: 10.1177/0886260519839422. [Epub ahead of print]

PMID:
30917734
28.

The glutathione system and the related thiol network in Caenorhabditis elegans.

Ferguson GD, Bridge WJ.

Redox Biol. 2019 Jun;24:101171. doi: 10.1016/j.redox.2019.101171. Epub 2019 Mar 16. Review.

29.

Behavioral and Academic Adjustment of Remotely Acculturating Adolescents in Urban Jamaica.

Ferguson GM, Dimitrova R.

New Dir Child Adolesc Dev. 2019 Mar;2019(164):27-47. doi: 10.1002/cad.20278. Epub 2019 Mar 19.

PMID:
30891926
30.

A Global Cypher: The Role of Hip Hop in Cultural Identity Construction and Navigation for Southeast Asian American Youth.

Nguyen J, Ferguson GM.

New Dir Child Adolesc Dev. 2019 Mar;2019(164):99-115. doi: 10.1002/cad.20279. Epub 2019 Mar 19.

31.

Coaches' perceptions on qualities defining good adolescent rugby players and are important for player recruitment in talent identification programs: the SCRuM project.

Chiwaridzo M, Munambah N, Oorschot S, Magume D, Dambi JM, Ferguson G, Smits-Engelsman BCM.

BMC Res Notes. 2019 Mar 13;12(1):132. doi: 10.1186/s13104-019-4170-y.

32.

Ribosome Provisioning Activates a Bistable Switch Coupled to Fast Exit from Stationary Phase.

Remigi P, Ferguson GC, McConnell E, De Monte S, Rogers DW, Rainey PB.

Mol Biol Evol. 2019 May 1;36(5):1056-1070. doi: 10.1093/molbev/msz041.

33.

Repeated Phenotypic Evolution by Different Genetic Routes in Pseudomonas fluorescens SBW25.

Gallie J, Bertels F, Remigi P, Ferguson GC, Nestmann S, Rainey PB.

Mol Biol Evol. 2019 May 1;36(5):1071-1085. doi: 10.1093/molbev/msz040.

34.

That which does not kill you-May afflict you? Psychological trauma in bipolar disorder.

Landin-Romero R, Moreno-Alcázar A, Ferguson G, Pérez V, Amann BL.

Bipolar Disord. 2019 May;21(3):192-193. doi: 10.1111/bdi.12766. Epub 2019 Mar 13. No abstract available.

PMID:
30815972
35.

Subnanometer cobalt oxide clusters as selective low temperature oxidative dehydrogenation catalysts.

Lee S, Halder A, Ferguson GA, Seifert S, Winans RE, Teschner D, Schlögl R, Papaefthimiou V, Greeley J, Curtiss LA, Vajda S.

Nat Commun. 2019 Feb 27;10(1):954. doi: 10.1038/s41467-019-08819-5.

36.

High-school adolescents' motivation to rugby participation and selection criteria for inclusion in school rugby teams: coaches' perspective (the SCRuM project).

Chiwaridzo M, Ferguson G, Smits-Engelsman BCM.

BMC Res Notes. 2019 Feb 26;12(1):103. doi: 10.1186/s13104-019-4138-y.

37.

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.

Chupp G, Lugogo NL, Kline JN, Ferguson GT, Hirsch I, Goldman M, Zangrilli JG, Trudo F.

Ann Allergy Asthma Immunol. 2019 May;122(5):478-485. doi: 10.1016/j.anai.2019.02.016. Epub 2019 Feb 23.

38.

Being there: protocol for a scoping review of the medical education literature on grief support training for medical professionals.

Soklaridis S, Ferguson G, Bonato S, Saikaly R, Mosher PJ.

BMJ Open. 2019 Feb 22;8(11):e022778. doi: 10.1136/bmjopen-2018-022778.

39.
40.

Changing Social Norms: the Importance of "Organized Diffusion" for Scaling Up Community Health Promotion and Women Empowerment Interventions.

Cislaghi B, Denny EK, Cissé M, Gueye P, Shrestha B, Shrestha PN, Ferguson G, Hughes C, Clark CJ.

Prev Sci. 2019 Aug;20(6):936-946. doi: 10.1007/s11121-019-00998-3.

41.

Thought Spot: Embedding Usability Testing into the Development Cycle.

Sennah S, Shi J, Hollenberg E, Johnson A, Ferguson G, Abi-Jaoudé A, Wiljer D.

Stud Health Technol Inform. 2019;257:375-381.

PMID:
30741226
42.

Mixed methods assessment of women's risk of intimate partner violence in Nepal.

Clark CJ, Ferguson G, Shrestha B, Shrestha PN, Batayeh B, Bergenfeld I, Chang S, McGhee S.

BMC Womens Health. 2019 Jan 28;19(1):20. doi: 10.1186/s12905-019-0715-4.

43.

Percutaneous Arthroscopic-assisted Glenoid Fixation: A Novel Surgical Technique.

Tucker A, Donnelly K, Murphy L, Ferguson G, Sloan S, Charlwood P.

J Orthop Case Rep. 2018 Jul-Aug;8(4):3-6. doi: 10.13107/jocr.2250-0685.1132.

44.

Transdisciplinary team science for global health: Case study of the JUS Media? Programme.

Ferguson GM, Fiese BH, Nelson MR, Meeks Gardner JM.

Am Psychol. 2019 Sep;74(6):725-739. doi: 10.1037/amp0000383. Epub 2019 Jan 21.

PMID:
30667234
45.

Effects of baseline symptom burden on treatment response in COPD.

Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 4;14:181-194. doi: 10.2147/COPD.S179912. eCollection 2019.

46.

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers.

Wittbrodt ET, Millette LA, Evans KA, Bonafede M, Tkacz J, Ferguson GT.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 24;14:101-114. doi: 10.2147/COPD.S177213. eCollection 2019.

47.

Health-Related Quality of Life Improvements in Moderate to Very Severe Chronic Obstructive Pulmonary Disease Patients on Nebulized Glycopyrrolate: Evidence from the GOLDEN Studies.

Ferguson GT, Kerwin EM, Donohue JF, Ganapathy V, Tosiello RL, Bollu VK, Rajagopalan K.

Chronic Obstr Pulm Dis. 2018 Jun 6;5(3):193-207. doi: 10.15326/jcopdf.5.3.2017.0178.

48.

Disability status, intimate partner violence and perceived social support among married women in three districts of the Terai region of Nepal.

Gupta J, Cardoso LF, Ferguson G, Shrestha B, Shrestha PN, Harris C, Groce N, Clark CJ.

BMJ Glob Health. 2018 Oct 31;3(5):e000934. doi: 10.1136/bmjgh-2018-000934. eCollection 2018.

49.

Comment on "Groundwater Pumping Is a Significant Unrecognized Contributor to Global Anthropogenic Element Cycles".

Ferguson G, McIntosh JC.

Ground Water. 2019 Jan;57(1):82. doi: 10.1111/gwat.12840. Epub 2018 Nov 26. No abstract available.

PMID:
30478897
50.

Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor β Superfamily Type 1 Receptors.

Spender LC, Ferguson GJ, Hughes GD, Davies BR, Goldberg FW, Herrera B, Taylor RG, Strathearn LS, Sansom OJ, Barry ST, Inman GJ.

Mol Pharmacol. 2019 Feb;95(2):222-234. doi: 10.1124/mol.118.112946. Epub 2018 Nov 20.

PMID:
30459156

Supplemental Content

Loading ...
Support Center